Latest news: in the meta-analysis of Individual Participant Data, oral dydrogesterone was associated with a significantly higher chance of ongoing pregnancy (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.08 to 1.61; P = 0.0075) at 12 weeks of gestation and live birth (OR, 1.28; 95% CI, 1.04 to 1.57; P = 0.0214) compared to vaginal micronized progesterone¹.

Reference: 1. Griesinger G, Blockeel C,  Kahler E, et al. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLoS ONE 15(11): e0241044.https://doi. org/10.1371/journal.pone.0241044.

For the English version CLICK HERE.

For the Russian version CLICK HERE.